Φορτώνει......
Measuring microdose ABY-029 fluorescence signal in a primary human soft-tissue sarcoma resection
Microdose administration of ABY-029, an anti-epidermal growth factor receptor Affibody molecule conjugated to IRDye 800CW, is being studied in a Phase 0 trial for resection of soft-tissue sarcomas. The excised tissue of a single patient in the microdose administration group was imaged with both a wi...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Proc SPIE Int Soc Opt Eng |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
2019
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6783124/ https://ncbi.nlm.nih.gov/pubmed/31595101 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1117/12.2510935 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|